- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 137.6% over the previous month of $3.86bn and a rise of 17.3% when compared with the last 12-month average, which stood at $7.82bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $7.41bn. At the country level, the US topped the list in terms of deal value at $7.41bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of M&A deals activity in April 2021 was the US with 23 deals, followed by the Germany with six and the UK with four.
In 2021, as of April, medical devices M&A deals worth $38.99bn were announced globally, marking an increase of 1259.1% year on year.
medical devices industry M&A deals in April 2021: Top deals
The top five M&A deals accounted for 92.05% of the overall value during April 2021.
The combined value of the top five medical devices M&A deals stood at $8.44bn, against the overall value of $9.2bn recorded for the month.
The top five medical devices industry M&A deals of April 2021 tracked by GlobalData were:
1) $5bn merger deal with CA Healthcare Acquisition and LumiraDx
2) The $1.8bn acquisition of Luminex by DiaSorin
3) Hologic $795m acquisition deal with Mobidiag
4) The $626.41m acquisition of Pacific Radiology by Infratil
5) AddLife $216.53m acquisition deal with Vision Ophthalmology Group